Filing Flows › Rigel Pharmaceuticals (RIGL) › Product sales, net revenue
Rigel Pharmaceuticals (RIGL) Product sales, net revenue by quarter
Rigel Pharmaceuticals' Product sales, net revenue was $72.3M in Q3 2026 (third quarter 2026), +8% from Q2 2026. Over the last 7 quarters it ranged from $43.5M (Q1 2025) to $72.3M (Q3 2026).
| Quarter | Product sales, net revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $72.3M | +8% | +13% |
| Q2 2026 | $67.0M | +22% | +14% |
| Q1 2026 | $54.9M | -16% | +26% |
| Q4 2025 | $65.4M | +2% | — |
| Q3 2025 | $64.1M | +9% | — |
| Q2 2025 | $58.9M | +35% | — |
| Q1 2025 | $43.5M | — | — |
Q3 2026 at a glance
Rigel Pharmaceuticals, Q3 2026: revenue $80.9M (+16% year over year), operating margin 21.1%, net earnings $13.2M, operating cash flow $34.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Rigel Pharmaceuticals' Product sales, net revenue?
Rigel Pharmaceuticals' Product sales, net revenue was $72.3M in Q3 2026 (third quarter 2026), +8% from Q2 2026.
How has Rigel Pharmaceuticals' Product sales, net revenue changed?
Over the last 7 quarters it ranged from $43.5M (Q1 2025) to $72.3M (Q3 2026).